AIMP2 and lung carcinoma: Notably, AIMP2-DX2, a splicing variant of AIMP2 lacking exon 2, was induced by oncogenes in human lung cancer cells and could block oncogene-induced apoptosis and senescence by inhibiting p14/ARF68.